Supracricoid partial laryngectomies: Oncologic and functional results

Vincentiis, Marco de; Minni, Antonio; Gallo, Andrea; Nardo, Antonio Di

doi:10.1002/(sici)1097-0347(199809)20:6<504::aid-hed3>3.3.co;2-k

Cited by 50 publications

(93 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The literature reports 3-year survival rates between 71.4 and 95.7%, and 5-year survival rates between 79 and 88% [10][11][12][13][14][15]. In our series, the 3-and 5-year overall survival rates were 90.5 and 84.1%, respectively, with 3-and 5-year disease-specific survival rates of 95.4 and 92.5%, respectively.…”

Section: Discussionsupporting

confidence: 49%

Supracricoid laryngectomy with cricohyoidopexy: oncological results

Topaloğlu

Bal

Saltürk

2011

Eur Arch Otorhinolaryngol

View full text Add to dashboard Cite

This study assessed the oncological results in patients undergoing supracricoid laryngectomy with cricohyoidopexy. A cohort of 44 patients surgically treated using supracricoid laryngectomy with cricohyoidopexy between June 2001 and December 2009 was retrospectively analyzed. The mean follow-up period was 53.2 (±24.7) months. The Kaplan-Meier method was used to analyze overall survival and disease-specific survival, as well as survival according to T2 and T3 subgroups. Overall survival rates at 3 and 5 years were 90.5 and 84.1%, respectively. The 3- and 5-year disease-specific survival rates were 95.4 and 92.5%, respectively. Overall survival for patients with T2 disease was 87.5% at 3 years and 80.8% at 5 years. For T3, the corresponding rates were 91.8 and 87.0%. Disease-specific survival for patients with T2 disease was 93.3% at 3 years and the same at 5 years; the corresponding rates for T3 were 96.4 and 91.4%. The differences between T2 and T3 patients at 3 and 5 years with respect to overall and disease-specific survival were not statistically significant (P = 0.903 and P = 0.863, respectively). Recurrence was local in one patient (2.2%) and regional in three (6.8%). There were three distant metastases (6.8%) and one second primary carcinoma (2.2%). These findings support the use of supracricoid laryngectomy with cricohyoidopexy as an oncologically safe technique in properly selected patients with laryngeal carcinoma.

show abstract

Section: Discussionsupporting

confidence: 49%

Supracricoid laryngectomy with cricohyoidopexy: oncological results

Topaloğlu

Bal

Saltürk

2011

Eur Arch Otorhinolaryngol

View full text Add to dashboard Cite

show abstract

“…In Italy, starting in the 1970s following the eVorts of SeraWni [2], supracricoid partial laryngectomies (SCL) have been increasingly more adopted by head and neck surgeons as a type of functionpreserving surgery for the treatment of early (glottic T1b-T2; supraglottic T2) or locally advanced (glottic and supraglottic selected T3) laryngeal tumors. Many surgeons have shown that SCL, when faced with the planned sacriWce of the larynx compared to other therapeutic options, provides good, reproducible loco-regional control, and preserves laryngeal function, with the tracheostomy eventually closed in almost all patients [3][4][5][6][7].…”

Section: Introductionmentioning

confidence: 99%

Subtotal laryngectomy: outcomes of 469 patients and proposal of a comprehensive and simplified classification of surgical procedures

Rizzotto

Crosetti

Lucioni

et al. 2012

Eur Arch Otorhinolaryngol

View full text Add to dashboard Cite

Long-term oncological and functional results from a retrospective study on 469 patients over a 10-year period of subtotal laryngectomies (SL), 399 supracricoid partial laryngectomies (SCL) and 70 supratracheal partial laryngectomies (STL) are presented. The mean follow-up time was 97 months (range 60–165 months). Acute complications, types and rates of late sequelae, functional results, 2-year post-operative scores of laryngeal function and quality of life are reported. The observed long-term results were: SCL, 5-year overall and disease-free survival: 95.6, and 90.9%, respectively; 2-year post-operative laryngeal function preservation: 95.7%; STL, 5-year overall and disease-free survival: 80 and 72.9%, respectively; 2-year post-operative laryngeal function preservation: 80%. The performance status scale for laryngeal function preservation showed very high 2-year scores, with no significant differences depending on the type and extent of surgery. The adopted type of function-sparing surgery provided overall and disease-free survival rates that were somewhat better than those reported in studies based on organ-sparing protocols with chemoradiotherapy. The rate of total laryngectomy of completion in this series was 4.4%. A new classification of the current horizontal partial laryngectomies is also proposed, namely “Horizontal Laryngectomy System” (HOLS), based on the extent of surgical removal of laryngeal structures.

show abstract

“…Similar results have been reported in the literature over the last decade also with transoral laser microsurgery in patients with T3N0-N1 SLC [13][14][15][16][17][18][19]: 1-and 5-year DFS ranged between 71-96 and 46-78 %, respectively. However, a substantial percentage (18-53 %) of patients had adjuvant chemo-radiotherapy for positive resection margins or extracapsular extension of nodal disease: all these studies proved that partial surgery is a valid approach for the laryngeal preservation in selected T3 cases, but often induces the need for adjuvant treatments owing to the difficulties in obtaining clear margins.…”

Section: Discussionmentioning

confidence: 99%